MBOT Stock Analysis: Buy, Sell, or Hold?
MBOT - Microbot Medical, Inc. Common Stock
$2.37
0.07 (3.04%)
▲
5d:
-5.2%
30d:
-4.44%
90d:
+12.32%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
MBOT is down 5.6% this week, but smart money is accumulating calls. Top strike: $2.5 2026-05-15 with 10 OI. Call ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When MBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: MBOT is currently trading at $2.37, which is considered oversold relative to its 30-day fair value range of $2.30 to $2.68. From a valuation perspective, the stock is trading at a discount (Forward PE: -7.0) compared to its historical average (18.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $2.27, while resistance sits at $2.79. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+226.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $2.27, while resistance sits at $2.79. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+226.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.30 -
$2.68
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 226.1% below Wall St target ($7.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -5.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.30 -
$2.68
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.27
Resistance Level
$2.79
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.97
Wall Street Target
$7.50
(+226.1%)
PE vs Historical
-7.0 vs 18.5
CHEAP
Share & Embed Analysis
Last updated: March 31, 2026 11:14 AM ET
Data refreshes hourly during market hours. Next update: 12:14 PM
Data refreshes hourly during market hours. Next update: 12:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 55 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 61 BUY |
